LXEO- Lexeo Therapeutics, Inc.

Name: Lexeo Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lexeo Therapeutics, Inc. (LXEO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. LXEO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Townsend Richard Nolan	395.1K	$2.30M	-
COO	Otero Jose Manuel	131.4K	$766.0K	-
Other	Adler Eric	72.6K	$423.5K	-
Other	Robertson Jenny	68.4K	$398.7K	-
Other	See Tai Sandi	65.5K	$381.7K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 18, 2025	Townsend Richard Nolan76	Chief Executive Officer	Sell	1,127	$9.27	$10,447.29	-0.5%	-31.6%	-
Nov 18, 2025	Adler Eric	Chief Medical Officer	Sell	615	$9.27	$5,701.05	-0.8%	-31.6%	-
Nov 18, 2025	See Tai Sandi	Chief Development Officer	Sell	386	$9.27	$3,578.22	-0.6%	-31.6%	-
Nov 18, 2025	Robertson Jenny	Chief Legal Officer	Sell	549	$9.27	$5,089.23	-0.8%	-31.6%	-
Oct 17, 2025	Otero Jose Manuel	Chief Technical Officer	Sell	2,115	$8.94	$18,912.55	-1.6%	-21.7%	-
Oct 17, 2025	Townsend Richard Nolan76	Chief Executive Officer	Sell	13,133	$8.94	$117,436.00	-2.6%	-21.7%	-
Oct 17, 2025	Adler Eric	Chief Medical Officer	Sell	3,382	$8.94	$30,241.96	-2.3%	-21.7%	-
Oct 17, 2025	See Tai Sandi	Chief Development Officer	Sell	3,888	$8.94	$34,766.82	-2.9%	-21.7%	-
Oct 17, 2025	Robertson Jenny	Chief Legal Officer	Sell	3,526	$8.94	$31,529.85	-2.5%	-21.7%	-
Aug 18, 2025	Otero Jose Manuel	Chief Technical Officer	Sell	721	$9.27	$6,683.67	-1.1%	+92.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC